Treating diabetes with fewer side effects

Edgar181 [Public domain] via Wikimedia Commons

Thiazolidinediones are used to treat type 2 diabetes by targeting the insulin resistance that characterizes the disease through activation of the receptor PPARγ. This improves insulin sensitivity but also contributes to side effects such as weight gain, edema, increased risk of bone fractures and, for certain drugs, organ toxicity and cardiovascular problems. Such side effects may be severe enough to discourage people from taking the drugs. Hence, physicians and researchers have been seeking new therapies for improving insulin sensitivity without activating PPARγ.

Lab Anim. (NY) 41, 182 (2012).
view full text (login required)

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: